Oral presentation by Dr. Jacqueline French to outline sustained monthly reduction in focal onset seizures during open-label extension of X-TOLE study Poster to present the trial design for Phase 3 X-ACKT clinical… Read More
Takeda continues its commitment to delivering innovative therapies that allow Canadians with primary and secondary immunodeficiency to live their lives to the fullest TORONTO, ON — Takeda Canada Inc. (Takeda)… Read More
Proprietary ROVEr™ platform enables design of next-generation radiopharmaceuticals with tunable pharmacokinetic (PK) properties to maximize therapeutic effect and mitigate systemic toxicities Potential for alpha- or beta-emitting radiopharmaceuticals, for clinically validated… Read More
Fourth major clinical trial to select PharmAla Biotech as supplier in Australia VANCOUVER, BC — Globe Newswire — PharmAla Biotech is proud to have been selected as the MDMA manufacturing… Read More
Photodisinfection achieved complete elimination (>99.999% kill) against Salmonella enterica and 99.999% reduction of MRSA biofilm – exceeding food safety requirements Successful program made possible by Government of Canada and Canadian Agricultural… Read More
